Analysis of treatment and prognosis of 73 thymic carcinoma patients
JI Wei,FENG Qin-fu,ZHOU Zong-mei,WANG Mei,CHEN Dong-fu,ZHANG Hong-xing,XIAO Ze-fen,WANG Lu-hua,YIN Wei-bo,姬巍,冯勤富,周宗玫,汪楣,陈东福,张宏兴,肖泽芬,王绿化,殷蔚伯
DOI: https://doi.org/10.3760/j.issn:1004-4221.2006.02.007
2006-01-01
Abstract:Objective To define the clinical characteristics, treatment method and prognosis of thymic carcinoma. Methods From June 1962 to July 2003, 73 such patients were analyzed retrospectively. All were confirmed histopathology as thymic carcinoma, including 45 males and 28 females. Masaoka's system was used for staging(stage Ⅱ 1.4%, Ⅲ 47.9% and Ⅳ 50.7%). Forty patients(55%) were treated by surgery: total resection in 6 patients(15%), subtotal resection in 21 , and exploration only 13. Seventy patients(96%) were given radiotherapy with median of 60Gy. Chemotherapy was instincted in 30 patients(32%) with median of 4 cycles. Survival rate was calculated and the survival curve plotted by Kaplan-Meier method. The median follow-up time was 14 years. Results The overall 5-, 10-year survival rate was 31%, and 19%, respectively, with median survival time of 35.1 months. The 5-year survival rate was 45%, and 17% in stage Ⅲ, and Ⅳ, respectively(P=0.002). Five patients alive of 6 patients treated by total resection, 52% and 14% in those treated by subtotal resection and explored, unoperated groups, respectively(P=0.003). The 5-year survival rate in patients treated by chemotherapy was 28% and 33% in those not treated by chemotherapy(P=0.671). Incidence of radiation pericarditis and radiation pneumonitis was 7% and 9%, respectively. Thirteen patients(36%) failed in 36 patients with stage Ⅱ,Ⅲ lesions: 4 patients by local relapse, and 7 by distant metastasis, and 2 by both local recurrence and distant metastasis. Conclusions The prognosis of thymic carcinoma is poor. Masaoka staging and type of tumor resection are significant prognosis factors. The complication of radiotherapy was mild. The role of chemotherapy is unclear.